We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$720M
AUM Growth
-$214M
Cap. Flow
+$56.8M
Cap. Flow %
7.89%
Top 10 Hldgs %
53.82%
Holding
93
New
36
Increased
15
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$16.4M
2
BIIB icon
Biogen
BIIB
+$11.8M
3
ADBE icon
Adobe
ADBE
+$11M
4
PANW icon
Palo Alto Networks
PANW
+$10.9M
5
KRNT icon
Kornit Digital
KRNT
+$9.29M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.5M
2
FIVN icon
FIVE9
FIVN
+$12.8M
3
ALT icon
Altimmune
ALT
+$11.7M
4
NICE icon
Nice
NICE
+$10.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 66.85%
2 Miscellaneous 22.37%
3 Technology 7.17%
4 Industrials 1.24%
5 Consumer Discretionary 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOWL icon
51
Werewolf Therapeutics
HOWL
$46.7M
$2.83M 0.39%
626,810
+29,807
+5% +$162K
RIGL icon
52
Rigel Pharmaceuticals
RIGL
$856M
$2.55M 0.35%
216,259
-36,241
-14% -$490K
PMVP icon
53
PMV Pharmaceuticals
PMVP
$78M
$2.23M 0.31%
187,800
– –
STOK icon
54
Stoke Therapeutics
STOK
$1.84B
$2.02M 0.28%
+157,200
New +$2.51M
RUN icon
55
Sunrun
RUN
$2.14B
$1.79M 0.25%
+65,000
New +$2.02M
INFI
56
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.76M 0.24%
+1,476,000
New +$1.59M
ALPN
57
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.44M 0.2%
+200,000
New +$1.65M
ALT icon
58
PUT
Altimmune
ALT
$628M
$1.28M 0.18%
+100,000
New +$1.48M
MGIC
59
DELISTED
Magic Software Enterprises
MGIC
$1.26M 0.18%
81,293
– –
VRNA
60
DELISTED
Verona Pharma
VRNA
$1.23M 0.17%
+120,000
New +$1.01M
PSTX
61
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.06M 0.15%
+300,000
New +$992K
MDWD icon
62
MediWound
MDWD
$171M
$958K 0.13%
+98,388
New +$1.24M
ICL icon
63
ICL Group
ICL
$7.16B
$912K 0.13%
+111,482
New +$1.04M
NICE icon
64
Nice
NICE
$6.21B
$592K 0.08%
3,145
-52,337
-94% -$10.9M
EWTX icon
65
Edgewise Therapeutics
EWTX
$4.94B
$590K 0.08%
+60,000
New +$606K
ONCR
66
DELISTED
Oncorus, Inc.
ONCR
$459K 0.06%
540,258
– –
U icon
67
Unity
U
$18.6B
$366K 0.05%
+11,500
New +$473K
BGMS
68
Bio Green Med Solution Inc
BGMS
$6.5M
$365K 0.05%
+69
New +$351K
IMTXW
69
DELISTED
Immatics N.V. Warrants
IMTXW
$271K 0.04%
100,000
– –
ARBE icon
70
Arbe Robotics
ARBE
$85.9M
$259K 0.04%
43,165
– –
OTMO
71
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$111K 0.02%
26,124
– –
ABNB icon
72
Airbnb
ABNB
$97.8B
– –
-27,700
Closed -$2.47M
ALNY icon
73
CALL
Alnylam Pharmaceuticals
ALNY
$32.4B
– –
-75,000
Closed -$10.9M
AMD icon
74
Advanced Micro Devices
AMD
$891B
– –
-15,773
Closed -$1.21M
CCCC icon
75
C4 Therapeutics
CCCC
$421M
– –
-705,736
Closed -$5.32M
1 2
3
4

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sphera Funds Management held 93 positions worth $720M, down 23% from $935M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sphera Funds Management deployed $56.8M of net new capital in Q3 2022, opening 36 new positions and adding to 15 existing holdings. Its largest new stake was Biogen: 55,500 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 48% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Altimmune, an estimated $11.7M trimmed.

  • Sphera Funds Management's largest Q3 2022 buy was Biogen: 55,500 shares worth $14.8M.
  • Sphera Funds Management added most to Sanofi in Q3 2022, an estimated $16.4M increase.
  • Sphera Funds Management's biggest Q3 2022 reduction was Altimmune, cutting an estimated $11.7M.
  • Sphera Funds Management fully exited State Street SPDR S&P Biotech ETF in Q3 2022, selling an estimated $32.5M.
  • Sphera Funds Management's ten largest holdings make up 54% of its $720M portfolio in Q3 2022.
  • Sphera Funds Management opened 36 new positions and closed 19 in Q3 2022.
  • Sphera Funds Management's portfolio value fell 23% quarter-over-quarter to $720M.

Based on Sphera Funds Management's 13F filing for Q3 2022, filed 14 Nov 2022.